Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Guava leaf extract may help treat hair loss and protect cells by blocking certain genes and fighting damaging molecules.

A rare pituitary tumor in an 18-year-old male caused hormonal issues and vision loss, requiring surgery and further treatment.

Melatonin may inhibit melanoma growth and has potential as a cancer therapy aid, but its effects on human skin pigmentation need more research.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Platelet-Rich Plasma (PRP) has potential benefits in plastic surgery, especially for skin grafts, wound healing, hair loss, mild Carpal Tunnel Syndrome, and TMJ disorders, but more research is needed to confirm its effectiveness.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Reflectance confocal microscopy can tell apart white dots on the scalp as either sweat gland ducts or hair follicle openings.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

The scaffold effectively prevents melanoma relapse and aids wound healing.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Cetuximab can cause eyelash growth, which is rare but manageable.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Endocrine therapies for cancer significantly increase the risk of hair loss.